Alibaba: Nothing Has Changed To Make Buys Compelling (Archive)
Alibaba remains a value trap without clear sales or margin recovery catalysts yet.
5-Minute Pitches
5-Minute Stock Pitches. Expect 10–20 pitches focused on core stock drivers every month.
Ares Capital: Competition Weighs Down On Yields And Margins (Archive)
Competitive pressures erode Ares Capital’s high-yield deal access and compress net investment margins.
Energy Transfer: Less Attractive For Fresh Buyers (Archive)
Valuation discounts have narrowed and technicals point to fading upside for incremental buyers.
Why NVIDIA Is Not Yet In Its Hype Cycle (Archive)
NVIDIA is growing in multiples, margins are soaring, and valuations still avoid true hype.
Super Micro Computer: The Time Correction Is Not Yet Over (Archive)
SMCI’s stellar AI-driven growth persists, but margins, ROICs, and valuation temper conviction.
Pfizer: Too Early For A Turnaround (Archive)
Pfizer’s oncology pivot and CEO incentives cloud the timing and quality of any turnaround.
Palantir: Insider Sales And High Valuations Vs. Strong Operational Performance (Archive)
Palantir’s strong execution contrasts with heavy insider selling and stretched valuations.